MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells

Molecules and Cells

Volumn 35, Issue 1, 2013, Pages 17-24

  Kim, Jae Sung ^a   Yu, Sun Kyoung ^a   Lee, Myoung Hwa ^a   Park, Min Gyeong ^a   Park, Euteum ^a   Kim, Su Gwan ^a   Lee, Sook Young ^a   Kim, Chun Sung ^a   Kim, Heung Joong ^a   Chun, Hong Sung ^a   Chun, Sang Woo ^b   Kim, Do Kyung ^a  

^a Chosun University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

apoptosis; human oral cancer; interleukin 24; microRNA 205

Indexed keywords

CASPASE 3; CASPASE 7; INTERLEUKIN 24; MICRORNA 205;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUTH CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CASPASES; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKINS; KB CELLS; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84872850811     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-2154-7     Document Type: Article

References (45)

1. Adachi, R.; Horiuchi, S.; Sakurazawa, Y.; Hasegawa, T.; Sato, K.; and Sakamaki, T. (2011). ErbB2 down-regulates microRNA-205 in breast cancer. Biochem. Biophys. Res. Commun. 411, 804-808.
2. Bentwich, I. (2005). A postulated role for microRNA in cellular differentiation. FASEB J. 19, 875-879.
3. Bhatnagar, N.; Li, X.; Padi, S.K.; Zhang, Q.; Tang, M.S.; and Guo, B. (2010). Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis. 1, e105.
4. Boll, K.; Reiche, K.; Kasack, K.; Morbt, N.; Kretzschmar, A.K.; Tomm, J.M.; Verhaegh, G.; Schalken, J.; von Bergen, M.; Horn, F.; et al. (2012). MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene [Epub ahead of print]
5. Bonnet, E.; Wuyts, J.; Rouze, P.; and Van de Peer, Y. (2004). Evidence that microRNA precursors, unlike other non-coding RNAs, have lower folding free energies than random sequences. Bioinformatics 20, 2911-2917.
6. Brennecke, J.; Hipfner, D.R.; Stark, A.; Russell, R.B.; and Cohen, S.M. (2003). bantam encodes a developmentally regulated micro-RNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36.
7. Carrington, J.C.; and Ambros, V. (2003). Role of microRNAs in plant and animal development. Science 301, 336-338.
8. Caudell, E.G.; Mumm, J.B.; Poindexter, N.; Ekmekcioglu, S.; Mhashilkar, A.M.; Yang, X.H.; Retter, M.W.; Hill, P.; Chada, S.; and Grimm, E.A. (2002). The protein product of the tumor suppressor gene, melanoma differentiation- associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 168, 6041-6046.
9. Chada, S.; Sutton, R.B.; Ekmekcioglu, S.; Ellerhorst, J.; Mumm, J.B.; Leitner, W.W.; Yang, H.Y.; Sahin, A.A.; Hunt, K.K.; Fuson, K.L.; et al. (2004). MDA-7/IL-24 is a unique cytokine - tumor suppressor in the IL-10 family. Int. Immunopharmacol. 4, 649-667.
10. Chen, Y.J.; Chang, J.T.; Liao, C.T.; Wang, H.M.; Yen, T.C.; Chiu, C.C.; Lu, Y.C.; Li, H.F.; and Cheng, A.J. (2008). Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 99, 1507-1514.
11. Cho, W.J.; Shin, J.M.; Kim, J.S.; Lee, M.R.; Hong, K.S.; Lee, J.H.; Koo, K.H.; Park, J.W.; and Kim, K.S. (2009). miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol. Cells 28, 521-527.
12. Dar, A.A.; Majid, S.; de Semir, D.; Nosrati, M.; Bezrookove, V.; and Kashani-Sabet, M. (2011). miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J. Biol. Chem. 286, 16606-16614.
13. Didiano, D.; and Hobert, O. (2008). Molecular architecture of a miRNA-regulated 3′ UTR. RNA 14, 1297-1317.
14. Elwood, J.M.; Pearson, J.C.; Skippen, D.H.; and Jackson, S.M. (1984). Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int. J. Cancer 34, 603-612.
15. Feber, A.; Xi, L.; Luketich, J.D.; Pennathur, A.; Landreneau, R.J.; Wu, M.; Swanson, S.J.; Godfrey, T.E.; and Litle, V.R. (2008). MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 135, 255-260; discussion 260.
16. Fujita, S.; and Iba, H. (2008). Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates. Bioinformatics 24, 303-308.
17. Gopalan, B.; Shanker, M.; Scott, A.; Branch, C.D.; Chada, S.; and Ramesh, R. (2008). MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity. Cancer Gene Ther. 15, 1-8.
18. Gopalkrishnan, R.V.; Sauane, M.; and Fisher, P.B. (2004). Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24. Int. Immunopharmacol. 4, 635-647.
19. Gottardo, F.; Liu, C.G.; Ferracin, M.; Calin, G.A.; Fassan, M.; Bassi, P.; Sevignani, C.; Byrne, D.; Negrini, M.; Pagano, F.; et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25, 387-392.
20. Gupta, P.; Su, Z.Z.; Lebedeva, I.V.; Sarkar, D.; Sauane, M.; Emdad, L.; Bachelor, M.A.; Grant, S.; Curiel, D.T.; Dent, P.; et al. (2006). mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol. Ther. 111, 596-628.
21. Hanna, J.A.; Hahn, L.; Agarwal, S.; and Rimm, D.L. (2012). In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Lab. Invest. 92, 1390-1397.
22. Iorio, M.V.; Casalini, P.; Piovan, C.; Di Leva, G.; Merlo, A.; Triulzi, T.; Menard, S.; Croce, C.M.; and Tagliabue, E. (2009). microRNA-205 regulates HER3 in human breast cancer. Cancer Res. 69, 2195-2200.
23. Jiang, X.; Xiang, G.; Wang, Y.; Zhang, L.; Yang, X.; Cao, L.; Peng, H.; Xue, P.; and Chen, D. (2012). MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-beta RII. Mol. Cells 33, 545-551.
24. Karaayvaz, M.; Zhang, C.; Liang, S.; Shroyer, K.R.; and Ju, J. (2012). Prognostic significance of miR-205 in endometrial cancer. PLoS One 7, e35158.
25. Lebedeva, I.V.; Emdad, L.; Su, Z.Z.; Gupta, P.; Sauane, M.; Sarkar, D.; Staudt, M.R.; Liu, S.J.; Taher, M.M.; Xiao, R.; et al. (2007). mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int. J. Oncol. 31, 985-1007.
26. Liu, S.; Tetzlaff, M.T.; Liu, A.; Liegl-Atzwanger, B.; Guo, J.; and Xu, X. (2012). Loss of microRNA-205 expression is associated with melanoma progression. Lab. Invest. 92, 1084-1096.
27. Lynam-Lennon, N.; Maher, S.G.; and Reynolds, J.V. (2009). The roles of microRNA in cancer and apoptosis. Biol. Rev. Camb. Philos. Soc. 84, 55-71.
28. Majid, S.; Dar, A.A.; Saini, S.; Yamamura, S.; Hirata, H.; Tanaka, Y.; Deng, G.; and Dahiya, R. (2010). MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116, 5637-5649.
29. Majid, S.; Saini, S.; Dar, A.A.; Hirata, H.; Shahryari, V.; Tanaka, Y.; Yamamura, S.; Ueno, K.; Zaman, M.S.; Singh, K.; et al. (2011). MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res. 71, 2611-2621.
30. Matsushima, K.; Isomoto, H.; Yamaguchi, N.; Inoue, N.; Machida, H.; Nakayama, T.; Hayashi, T.; Kunizaki, M.; Hidaka, S.; Nagayasu, T.; et al. (2011). MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J. Transl. Med. 9, 30.
31. Nahvi, A.; Shoemaker, C.J.; and Green, R. (2009). An expanded seed sequence definition accounts for full regulation of the hid 3′ UTR by bantam miRNA. RNA 15, 814-822.
32. O'Hara, A.J.; Vahrson, W.; and Dittmer, D.P. (2008). Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma. Blood 111, 2347-2353.
33. Sauane, M.; Gopalkrishnan, R.V.; Sarkar, D.; Su, Z.Z.; Lebedeva, I.V.; Dent, P.; Pestka, S.; and Fisher, P.B. (2003). MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14, 35-51.
34. Sauane, M.; Su, Z.Z.; Gupta, P.; Lebedeva, I.V.; Dent, P.; Sarkar, D.; and Fisher, P.B. (2008). Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc. Natl. Acad. Sci. USA 105, 9763-9768.
35. Sempere, L.F.; Christensen, M.; Silahtaroglu, A.; Bak, M.; Heath, C.V.; Schwartz, G.; Wells, W.; Kauppinen, S.; and Cole, C.N. (2007). Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 67, 11612-11620.
36. Song, H.; and Bu, G. (2009). MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. Biochem. Biophys. Res. Commun. 388, 400-405.
37. Tian, H.; Wang, J.; Zhang, B.; Di, J.; Chen, F.; Li, H.; Li, L.; Pei, D.; and Zheng, J. (2012). MDA-7/IL-24 induces Bcl-2 denitrosylation and ubiquitin-degradation involved in cancer cell apoptosis. PLoS One 7, e37200.
38. Unver, T.; Bakar, M.; Shearman, R.C.; and Budak, H. (2010). Genome-wide profiling and analysis of Festuca arundinacea miRNAs and transcriptomes in response to foliar glyphosate application. Mol. Genet. Genomics 283, 397-413.
39. Wang, Y.; and Lee, C.G. (2009). MicroRNA and cancer - focus on apoptosis. J. Cell. Mol. Med. 13, 12-23.
40. Wang, G.; Chan, E.S.; Kwan, B.C.; Li, P.K.; Yip, S.K.; Szeto, C.C.; and Ng, C.F. (2012). Expression of microRNAs in the urine of patients with bladder cancer. Clin. Genitourin Cancer 10, 106-113.
41. Warnakulasuriya, S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309-316.
42. Wu, H.; and Mo, Y.Y. (2009). Targeting miR-205 in breast cancer. Expert Opin. Ther. Targets 13, 1439-1448.
43. Wu, H.; Zhu, S.; and Mo, Y.Y. (2009). Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. 19, 439-448.
44. Xu, Y.; Brenn, T.; Brown, E.R.; Doherty, V.; and Melton, D.W. (2012). Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br. J. Cancer 106, 553-561.
45. Yue, X.; Wang, P.; Xu, J.; Zhu, Y.; Sun, G.; Pang, Q.; and Tao, R. (2012). MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol. Rep. 27, 1200-1206.